Industry Session
SATURDAY, NOVEMBER 1, 2014
EVIDENCE AND PERCEPTIONS IN HEMOPHILIA TREATMENT
Supported by Bayer
Chairperson
Pier Mannuccio Mannucci, Italy
08:30-08:35
Introduction
Pier Mannuccio Mannucci, Italy
08:35-09:00
Advances in the development of new short-acting therapies
Robert Klamroth, Germany
09:00-09:25
Emerging long-acting therapies: State of the art
Pier Mannuccio Mannucci, Italy
09:25-09:50
Debate: Will long acting replace short-acting as the standard of care?
Paul Giangrande, UK
Craig Kessler, USA
09:50-10:00
Summary, discussion and Q&A
Pier Mannuccio Mannucci, Italy
This session is not included in the CME/CPD credit program